Malignant lymphoma (disorder)
Year Started: 2017
Collection of B cell Lymphoid Malignancies including CLL, HCL, SLL, FL,SMZL, MCL
- Access:
- Open in response to specific calls
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Outside EU access restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Biomarker datasets | 0 - 3 months |
| Clinical records | 0 - 3 months |
| Followup records | 0 - 3 months |
| Freezer temperature logs | 3 - 6 months |
| Imaging data | 0 - 3 months |
| Pathology records | 0 - 3 months |
| Physiological/biochemical measurements | 3 - 6 months |
| Primary care records | 0 - 3 months |
| Quality indicators | 3 - 6 months |
| Treatment records | 0 - 3 months |
| Donor Ethnicity | 0 - 3 months |
Male
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 75% -99% | |
| Plasma | -60°C to -85°C | N/A | Affected | 11 - 25% | |
| Serum | -60°C to -85°C | N/A | Affected | 11 - 25% |
Female
Adult (> 40 years)
101 - 500 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 75% -99% | |
| Plasma | -60°C to -85°C | N/A | Affected | 11 - 25% | |
| Serum | -60°C to -85°C | N/A | Affected | 11 - 25% |